Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
127M
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
64.2M
-
Shares change
-
+453K
-
Total reported value, excl. options
-
$183M
-
Value change
-
+$1.29M
-
Put/Call ratio
-
0.05
-
Number of buys
-
29
-
Number of sells
-
-13
-
Price
-
$2.85
Significant Holders of Nautilus Biotechnology, Inc. - Common Stock, $0.0001 par value per share (NAUT) as of Q3 2024
84 filings reported holding NAUT - Nautilus Biotechnology, Inc. - Common Stock, $0.0001 par value per share as of Q3 2024.
Nautilus Biotechnology, Inc. - Common Stock, $0.0001 par value per share (NAUT) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64.2M shares
of 127M outstanding shares and own 50.59% of the company stock.
Largest 10 shareholders include AH Capital Management, L.L.C. (17.7M shares), PERCEPTIVE ADVISORS LLC (12.6M shares), Cercano Management LLC (7.17M shares), Madrona Venture Group, LLC (6.02M shares), BlackRock, Inc. (3.57M shares), VANGUARD GROUP INC (2.77M shares), Comprehensive Financial Management LLC (2.21M shares), Bain Capital Life Sciences Investors, LLC (2M shares), AMAZON COM INC (1.46M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.14M shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.